Grovcap ETFsGrovcap ETFs
LearnOptimizeSignals (Soon)Pulse (Soon)Institutional (Soon)Ask (Soon)

VanEck Genomics and Healthcare Innovators UCITS ETF

CURE · IE000B9PQW54 · VanEck

Key facts

Ticker
CURE
ISIN
IE000B9PQW54
Asset class
Equity
Category
Thematic
Distribution
Accumulating
Hedged
Not currently available

Benchmark & index

Benchmark
Not currently available
Index tracked
Not currently available
Replication
Not currently available

Costs & size

TER (ongoing charge)
0.35%
AUM
$13.4M · as of 24 Jul 2026
AUM currency
USD

Fund structure

Launch date
2 Sept 2022
Fund domicile
Ireland
UCITS status
ucits
Base currency
Not currently available
Share class currency
USD
Currency exposure
Not currently available
SFDR
Article 9

Listings

  • CURENot currently available
Data provenance
Source: Not currently available
Source last checked: 27 Jul 2026
Record last updated: 27 Jul 2026
Enrichment status: imported

Disclaimer

The information provided by Grovcap is for informational and educational purposes only and does not constitute investment, financial, legal, or tax advice. Investing involves risk, including the possible loss of capital. Always conduct your own research or consult a qualified professional before making investment decisions.

Your responses to quizzes, surveys, and other interactive features may be used in aggregated and anonymized form to improve Grovcap and generate investor insights. We do not sell personally identifiable information to third parties. For more information about how we collect, use, and protect your data, please refer to our Privacy Policy.